麦默通旋切手术与常规切除术治疗良性乳腺肿瘤的效果比较被引量：2

下载PDF

导出

摘要目的比较麦默通旋切手术与常规切除术治疗良性乳腺肿瘤的效果。方法选取2015年7月至2017年2月长垣县人民医院收治的95例良性乳腺肿瘤患者,共发现肿瘤115个,依据手术方案分为对照组(常规乳腺肿瘤切除术,47例)与观察组(麦默通旋切手术,48例)。对比两组手术相关情况及并发症发生率。结果观察组手术时间及住院时间短于对照组,术中出血量少于对照组,瘢痕宽度小于对照组,并发症发生率低于对照组,差异有统计学意义(P<0.05)。结论与常规乳腺肿瘤切除术比较,麦默通微创旋切术具有手术创伤小、术后并发症发生率低以及患者美观满意度高等优势。

作者薛卫杰

机构地区长垣县人民医院普外科

出处《河南医学研究》 CAS 2018年第10期1869-1870,共2页 Henan Medical Research

关键词麦默通旋切手术常规乳腺肿瘤切除术良性乳腺肿瘤

分类号 R655.8 [医药卫生—外科学]

引文网络
相关文献

参考文献5

1郑丽华,刘荣,张萌萌,刘运江.对侧乳腺癌发生的危险因素[J].中华肿瘤杂志,2015,37(4):241-243. 被引量：7
2王轶群.麦默通微创旋切手术与常规乳腺肿物切除术治疗良性乳腺肿物的临床疗效对比分析[J].临床和实验医学杂志,2014,13(8):636-639. 被引量：89
3宋宛芝,高晋南,杨海波.乳腺癌的流行状况及发病特征[J].中国药物与临床,2017,17(2):228-229. 被引量：40
4姜炬芳,李天牧,陈振玲.人乳腺肿瘤原代细胞的分离培养[J].中国药物与临床,2016,16(9):1245-1246. 被引量：1
5黄清丰,翟雪雁,吕晶,张兰,付倩,霍彦平.麦默通微创旋切术筛查早期乳腺癌的应用[J].山东医药,2014,54(34):105-105. 被引量：9

二级参考文献47

1Qutob O, Elahi B, Garimella V, et al. Minimally invasive excision of gynaecomastia - - a novel and effective surgical technique [ J ]. Ann R Coil Surg Engl, 2010,92(3) :198 -200.
2Luo H J, Chen X, Tu G, et al. Therapeutic application of ultrasound - guided 8 - gauge Mammotome system in presumed benign breast lesions [J]. Breast J, 2011,17(5) :490 -497.
3Lucivero G, Romano C, Ferraraccio F, et al. Lupus mastitis in systemic lupus erythematosus: a rare condition requiting a minimally invasive di- agnostic approach [ J ]. Int J Immunopathol Pharmacol, 2011,24 ( 4 ) : 1125 - 1129.
4Fahrbach K,Sledge I,Cella C,et al.A comparison of the accuracy of two minimally invasive breast biopsy methods:a systematic litera-ture review and meta-analysis[J].Arch Gynecol Obstet,2006,274(2):63-73.
5Yu YH,Liang C,Yuan XZ.Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma:a meta-analysis and systematic review[J].Breast Cancer Res Treat,2010,120(2):469-479.
6Youk JH,Kim EK,Kim MJ,et al.Sonographically guided 14-gauge core needle biopsy of breast masses:a review of 2420 cases with long-term follow-up[J].AJR Am J Roentgenol,2008,190(1):202-207.
7Fisher CS, Martin-Dunlap T, Ruppel MB, et al. Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age[J] . Ann Surg Oncol, 2012,19(10) :3246-3250.
8Khan SA. Contralateral prophylactic mastectomy: what do we know and what do our patients know[J].J Clin Oncol, 2011, 29 (16) :2132-2135.
9Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study[J]. IntJ Radiat Oncol Bioi Phys, 2003, 56( 4) : 1038-1045.
10Saltzman BS, Malone KE, McDougallJA, et al. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast oancerj]]. Breast Cancer Res Treat, 2012, 135(3) :849-855.